SL Industries, Inc. (NYSEMKT: SLI) net profit margin is 4.10% and weekly performance is -4.03%. On last trading day company shares ended up $29.75. SL Industries, Inc. (NYSEMKT: SLI) distance from 50-day simple moving average (SMA50) is 2.61%.
On 29 MAY Interphase Corporation (NASDAQ:INPH) announced its award-winning hand held device, is officially in production and will begin shipping. The product launched to critical acclaim at DEMO Spring 2012 , was a 2014 Honoree of the Consumer Electronics Show Innovations in Design and Engineering Award, and has captured the attention of the education technology market during its rigorous research and development phase. Interphase Corporation (NASDAQ:INPH) shares fell -14.16% in last trading session and ended the day on $4.97. INPH Gross Margin is 38.90% and its return on assets is -18.40%. Interphase Corporation (NASDAQ:INPH) quarterly performance is 9.23%.
On 10 JUNE Finjan Holdings, Inc. (NASDAQ:FNJN) said it committed to enabling innovation through the licensing of its intellectual property, provides an update to clarify a recent docket order in the matter of Finjan, Inc. v. FireEye, Inc. (Civ. No. 4:13-cv-03133 SBA) in the United States District Court for the Northern District of California, in which the Court corrected an error in the official Docket. Specifically, Docket No. 74 (June 6, 2014), entitled “AMENDED Report on the Filing or Determination of an Action Regarding a Patent or Trademark” corrected an earlier filed report (Docket No. 73, June 4, 2014) for an “Order of Dismissal.” The newly updated Docket No. 74 entry is an Order for Stay pending reexamination of Finjan’s U.S. Patent Nos. 7,058,822 and 7,647,633. Finjan Holdings, Inc. (NASDAQ:FNJN) shares moved down -4.86% in last trading session and was closed at $4.11, while trading in range of $4.08 -$ 4.66. Finjan Holdings, Inc. (NASDAQ:FNJN) year to date (YTD) performance is -36.08%.
On 16 JUNE CollabRx Inc (NASDAQ:CLRX) announced the successful launch of CancerRx(TM) – an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options. CancerRx was formally introduced to physicians at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting that took place May 30-June 3, 2014 in Chicago. CollabRx Inc (NASDAQ:CLRX) ended the last trading day at $1.96. Company weekly volatility is calculated as 12.77% and price to cash ratio as 2.18. CollabRx Inc (NASDAQ:CLRX) showed a negative weekly performance of -30.99%.
On 18 JUNE Agilysys, Inc. (NASDAQ:AGYS) said it has introduced Agilysys Analytics v2.0, a made-for-hospitality business intelligence solution that consolidates data across disparate systems and multiple locations into a single integrated source for comprehensive reporting, auditing and predictive analysis. Agilysys, Inc. (NASDAQ:AGYS) net profit margin is 16.90% and weekly performance is -2.68%. On last trading day company shares ended up $13.78. Analysts mean target price for the company is $15.00. Agilysys, Inc. (NASDAQ:AGYS) distance from 50-day simple moving average (SMA50) is 3.70%.